These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15212145)

  • 1. Physicians' reasons for not entering their patients in a randomized controlled trial in Japan.
    Rahman M; Morita S; Fukui T; Sakamoto J
    Tohoku J Exp Med; 2004 Jun; 203(2):105-9. PubMed ID: 15212145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicians' attitudes towards and reasons for participation in the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial.
    Rahman M; Morita S; Fukui T; Sakamoto J
    J Epidemiol; 2005 Mar; 15(2):38-40. PubMed ID: 15762092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Informed consent: the physicians' perspective.
    Taylor KM; Kelner M
    Soc Sci Med; 1987; 24(2):135-43. PubMed ID: 3563556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicians' choice in using Internet and fax for patient recruitment and follow-up in a randomized controlled trial.
    Rahman M; Morita S; Fukui T; Sakamoto J
    Methods Inf Med; 2004; 43(3):268-72. PubMed ID: 15227556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer.
    Taylor KM; Margolese RG; Soskolne CL
    N Engl J Med; 1984 May; 310(21):1363-7. PubMed ID: 6717508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician response to informed consent regulations for randomized clinical trials.
    Taylor KM; Shapiro M; Soskolne CL; Margolese RG
    Cancer; 1987 Sep; 60(6):1415-22. PubMed ID: 3621123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Informed consent in the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial: a survey of collaborating physicians.
    Fukui T; Rahman M; Morita S; Sakamoto J
    Hypertens Res; 2006 Jul; 29(7):471-4. PubMed ID: 17044658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consent and randomized clinical trials: are there moral or design problems?
    Kopelman L
    J Med Philos; 1986 Nov; 11(4):317-45. PubMed ID: 3819603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized clinical trials of cancer treatment--a public opinion survey.
    Kemp N; Skinner E; Toms J
    Clin Oncol; 1984 Jun; 10(2):155-61. PubMed ID: 6734007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recruitment of patients for a clinical trial: factors on the physician side and reasons on the patient side.
    Fukui T; Rahman M; Shimbo T; Morita S; Sakamoto J
    Intern Med; 2006; 45(8):511-4. PubMed ID: 16702742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of informed consent and recruitment for clinical trials in the immediate preoperative period.
    Myles PS; Fletcher HE; Cairo S; Madder H; McRae R; Cooper J; Devonshire D; Hunt JO; Richardson J; Machlin H; Morgan EB; Moloney J; Downey G
    Anesthesiology; 1999 Oct; 91(4):969-78. PubMed ID: 10519499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethical decision making and patient autonomy: a comparison of physicians and patients in Japan and the United States.
    Ruhnke GW; Wilson SR; Akamatsu T; Kinoue T; Takashima Y; Goldstein MK; Koenig BA; Hornberger JC; Raffin TA
    Chest; 2000 Oct; 118(4):1172-82. PubMed ID: 11035693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients' and physicians' disagreement on patients' understanding of clinical cancer trial information: a pairwise pilot study of mirroring subjective assessments compared with objective measurements.
    Dellson P; Carlsson C; Nilbert M; Jernström H
    Trials; 2019 May; 20(1):301. PubMed ID: 31142346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovations in the design of clinical trials in breast cancer.
    Zelen M
    Breast Cancer Res Treat; 1983; 3(2):137-42. PubMed ID: 6616074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conduct of emergency research in patients unable to give consent--experiences and perceptions of patients, their consent providing next of kin, and treating physicians following a prehospital resuscitation trial.
    Kämäräinen A; Silfvast T; Saarinen S; Virta J; Virkkunen I
    Resuscitation; 2012 Jan; 83(1):81-5. PubMed ID: 21801702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethical communication in clinical trials. Issues faced by data managers in obtaining informed consent.
    Loh WY; Butow PN; Brown RF; Boyle F
    Cancer; 2002 Dec; 95(11):2414-21. PubMed ID: 12436450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The patient's right to information in Japan--legal rules and doctor's opinions.
    Hattori H; Salzberg SM; Kiang WP; Fujimiya T; Tejima Y; Furuno J
    Soc Sci Med; 1991; 32(9):1007-16. PubMed ID: 2047893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Informed consent for investigational chemotherapy: patients' and physicians' perceptions.
    Penman DT; Holland JC; Bahna GF; Morrow G; Schmale AH; Derogatis LR; Carnrike CL; Cherry R
    J Clin Oncol; 1984 Jul; 2(7):849-55. PubMed ID: 6737023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment rates and reasons for community physicians' non-participation in an interdisciplinary intervention study on leg ulceration.
    Herber OR; Schnepp W; Rieger MA
    BMC Med Res Methodol; 2009 Aug; 9():61. PubMed ID: 19682354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.